Recap of Second 340B ESP™ Basic User Training Webinar
On August 26, Second Sight Solutions, the owner of the 340B ESP™ platform, hosted the second in a series of webinars on 340B ESP™. The webinar, entitled Data Security, Privacy,…
RWC-340B Press Statement on Recent Actions Taken by Drug Manufacturers
Here is a press statement from RWC-340B president Shannon Stephenson regarding the recent actions taken by drug manufacturers Lilly, Novartis, Merck, Sanofi, and Astra Zeneca. In the statement, RWC-340B calls…
Manufacturers to Provide “340B Rebates” Through New Kalderos Software Platform
This week, Kalderos announced that it is launching its new “340B Pay” platform which, if implemented, would fundamentally change how the 340B drug discount program operates – shifting a manufacturer’s…
Reps. Matsui and Stewart Introduce Legislation to Protect 340B Hospitals During COVID-19 Pandemic
On July 29, Reps. Doris Matsui (D-CA) and Chris Stewart (R-UT) introduced a bill that would protect 340B hospitals from losing their covered entity status and allow flexibility in how…
Court Upholds Medicare Part B Reimbursement Cuts for 340B Drugs
The Court of Appeals for District of Columbia Circuit issued a 2-1 decision today upholding Medicare Part B reimbursement cuts for 340B drugs from ASP+6% to ASP-22.5%. The case is…
President Trump Signs Executive Orders on Lowering Drug Prices – Potential Impact for 340B Safety-Net Providers
On Friday, July 24, President Donald Trump signed four Executive Orders designed to lower the cost of prescription drugs. This alert will focus on three Orders that could impact 340B…
Sanofi Announces 340BESP Participation and Consequences
Following a recent announcement by drug manufacturer Merck, Sanofi recently sent letters to 340B covered entities with contract pharmacy arrangements to request that they participate in a new web-based platform, 340B…
Press Release: White House Executive Orders Undermine 340B Program
Washington, D.C. – Shannon Stephenson, president of RWC-340B, said, “The White House Executive Orders related to 340B set a very dangerous precedent at the worst time, when safety net providers…
Recent Actions by Drug Manufacturers Merck and Eli Lilly Pose a Threat to Safety-Net Provider’s Ability to Access Drugs at 340B Prices
Merck Requests That Covered Entities Submit Contract Pharmacy Claims to 340B ESP Drug manufacturer Merck recently sent letters to 340B covered entities with contract pharmacy arrangements to request that they…
USCHA Announces Virtual Conference and Free Registration
The US Conference on HIV/AIDS (USCHA) announced that this year’s conference will be held virtually on October 19-21, 2020. Registration is free for the first 4,000 community & non-profit registrants.…